This guide may contain affiliate links in the future. As of publication it does not. See our disclosure policy.

Our weekly sales data shows Dove Body Scrub holding the #1 position in the Bath & Body category on Olive Young’s domestic Korea sales chart. While widely available in Western markets, its strong momentum in South Korea highlights its crossover popularity among consumers seeking accessible body care routines.

Why It’s on Our Radar

According to Olive Young sales tracking, the product currently occupies the top rank in the Bath & Body segment. It is a physical body scrub formulated with a cream base and fine exfoliating particles designed for rough or dry skin. The brand markets the formula to offer gentle exfoliation while maintaining surface moisture balance during cleansing.

Price Range

Dove Body Scrub typically retails in the range of around $10–15 depending on the specific formula variant and retailer promotions. Prices fluctuate with sales events, so we suggest checking real-time pricing directly on retailer listings.

Where to Buy in the US

  • Amazon — Availability varies on Amazon US depending on regional stockists, so checking the current product listings is recommended.
  • YesStyle / Stylevana (ships from Asia) — These international beauty storefronts frequently carry Korean-market inventory of the product, with shipping direct from Asia.
  • Olive Young Global / US store — Direct shipping from South Korea is available via Olive Young Global, where the item is regularly listed alongside regional sales bundles.

The Bottom Line

Holding the #1 spot in Olive Young’s Bath & Body section, Dove Body Scrub represents a consistent staple for simple physical exfoliation. It suits consumers looking for affordable, daily-use body care that integrates easily into standard bath routines. Readers can monitor whether this item maintains its category placement on our weekly Korean Beauty Rankings.

Data source: Olive Young Korea sales ranking, tracked weekly by The Seoul Beauty Report. Rankings are facts; commentary is ours.